KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $4,608,386 | +556.1% | 14,560 | +349.5% | 0.03% | +500.0% |
| Q2 2023 | $702,399 | +334.9% | 3,239 | +294.0% | 0.01% | +400.0% |
| Q4 2022 | $161,523 | -97.7% | 822 | -97.4% | 0.00% | -97.4% |
| Q3 2022 | $7,003,000 | +566.3% | 31,134 | +274.7% | 0.04% | +550.0% |
| Q2 2022 | $1,051,000 | -47.8% | 8,310 | -47.6% | 0.01% | -64.7% |
| Q1 2022 | $2,012,000 | +31.2% | 15,872 | +35.7% | 0.02% | +13.3% |
| Q4 2021 | $1,533,000 | +55.5% | 11,699 | +45.1% | 0.02% | +25.0% |
| Q3 2021 | $986,000 | +381.0% | 8,061 | +347.3% | 0.01% | +500.0% |
| Q2 2021 | $205,000 | -24.1% | 1,802 | -19.7% | 0.00% | -33.3% |
| Q1 2021 | $270,000 | +12.0% | 2,245 | -27.9% | 0.00% | -25.0% |
| Q3 2020 | $241,000 | +17.0% | 3,112 | +68.8% | 0.00% | 0.0% |
| Q2 2020 | $206,000 | -29.0% | 1,844 | -52.0% | 0.00% | -20.0% |
| Q4 2019 | $290,000 | +211.8% | 3,845 | -32.6% | 0.01% | +150.0% |
| Q3 2019 | $93,000 | – | 5,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,885,602 | $135,763,000 | 12.56% |
| PFM Health Sciences, LP | 499,510 | $35,965,000 | 2.95% |
| Eventide Asset Management | 901,077 | $64,878,000 | 2.10% |
| ACUTA CAPITAL PARTNERS, LLC | 56,000 | $4,032,000 | 1.95% |
| Logos Global Management LP | 69,658 | $5,015,000 | 1.91% |
| Vivo Capital, LLC | 223,692 | $16,106,000 | 1.46% |
| Atika Capital Management LLC | 90,000 | $6,480,000 | 1.24% |
| EAM Global Investors LLC | 27,126 | $1,953,000 | 1.14% |
| EAM Investors, LLC | 40,516 | $2,917,000 | 0.91% |
| MOODY ALDRICH PARTNERS LLC | 25,844 | $1,861,000 | 0.56% |